IRCT20210822052258N1 IRCT 2021-09-15 Shiraz University of Medical Sciences Evaluation of the efficacy of topical Gabapentin for the treatment of pruritus in patients with Epidermolysis bullosa Evaluation of the efficacy of topical Gabapentin for the treatment of pruritus in patients with Epidermolysis bullosa, Faghihi hospital, 2021 2021-09-23 anticipated 19 Complete https://irct.ir/trial/58287 interventional Randomization: Not randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Blinding description: In each patient, two pruritic areas are defined for the use of medication or a placebo. The type of intervention in each lesion remains unclear to both, the patients and the researcher until the end of the study. Products are delivered within completely similar 50 gr containers. Containers are identified with adhesive labels (A or B) so the subjects and investigators are not aware of the kind of treatment in each lesion (double-blind design). 3 Epidermolysis bullosa. Intervention 1: Intervention group: Intervention group receives topical Gabapentine 10%(plus 10%Glycerine in base of cold cream)formulized and prepared in Dr.Rastegar pharmacy on the assigned side 3 times daily for 6 weeks . Intervention 2: Control group: Control group uses base cream(۱۰% glycerin in cold cream) on the assigned side 3times daily for 6 weeks. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information.